(Allergan plc)

	AGN latest price $149.0108 (-1.93%) ($147.6789 - $150.8163) on Tue. May. 29, 2018.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.9% (three month average)
RSI	66
Latest Price	$149.0108(-1.93%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.4% a day on average for past five trading days.
Weekly Trend	AGN advances 1.3% a week on average for past two weeks.
Market Behavior	Broad based sell-off for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(50%)    XLV(48%)    XBI(46%)    ARKG(45%)    SPY(45%)
Factors Impacting AGN price	AGN will decline at least -0.95% in a week (0% probabilities).   VIXM(-28%)    TLT(-21%)    UUP(-18%)    VXX(-15%)    DIA(-10%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.95% (StdDev 1.9%)
Hourly BBV	0 ()
Intraday Trend	-0.9%

Resistance Level	$150.13
5 Day Moving Average	$151.87(-1.88%)
10 Day Moving Average	$152.78(-2.47%)
20 Day Moving Average	$150.13(-0.75%)
To recent high	-10.2%
To recent low	5.5%
Market Cap	$49.129b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed